Back
FormFactor 10K Form
Buy
66
FORM
FormFactor
Last Price:
41.78
Seasonality Move:
4.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | FORM/FormFactor Quarterly |
2023-11-07 | 10Q | FORM/FormFactor Quarterly |
2023-08-08 | 10Q | FORM/FormFactor Quarterly |
2023-05-09 | 10Q | FORM/FormFactor Quarterly |
2022-11-01 | 10Q | FORM/FormFactor Quarterly |
2022-08-02 | 10Q | FORM/FormFactor Quarterly |
Receive FORM News And Ratings
See the #1 stock for the next 7 days that we like better than FORM
FORM Financial Statistics
Sales & Book Value
Annual Sales: | $663.1M |
---|---|
Cash Flow: | $17.79M |
Price / Cash Flow: | 66.5 |
Annual Sales: | $12.33 |
Price / Book: | 3.44 |
Profitability
EPS (TTM): | 1.74000 |
---|---|
Net Income (TTM): | $135.76M |
Gross Margin: | $258.58M |
Return on Equity: | 14.83% |
Return on Assets: | 12.19% |
FormFactor Earnings Forecast
Key FormFactor Financial Ratios
- The Gross Profit Margin over the past 24 years for FORM is 39.00%.
- The Selling, General & Administrative Expenses for FORM have been equal to 20.06% of Gross Profit Margin.
- The Research & Development expenses have been 17.46% of Revenue.
- The Interest Expense is 0.51% of Operating Income.
- The Net Earning history of FORM is 12.42% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 15 years.
FormFactor Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | FORM |
CUSIP: | 346375 |
Website: | formfactor.com |
Debt
Debt-to-Equity Ratio: | 0.01 |
---|---|
Current Ratio: | 4.76 |
Quick Ratio: | 3.65 |
Price-to-Earnings
Trailing P/E Ratio: | 40.38 |
---|---|
Forward P/E Ratio: | 25.39 |
FORM Technical Analysis vs Fundamental Analysis
Buy
66
FormFactor (FORM)
is a Buy
Is FormFactor a Buy or a Sell?
-
FormFactor stock is rated a Buy
The current FormFactor [FORM] share price is $42.40. The Score for FORM is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.